| Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders K Katisko, A Cajanus, O Jääskeläinen, A Kontkanen, P Hartikainen, ... Journal of neurology 267, 162-167, 2020 | 94 | 2020 |
| Astrocytes and microglia as potential contributors to the pathogenesis of C9orf72 repeat expansion-associated FTLD and ALS H Rostalski, S Leskelä, N Huber, K Katisko, A Cajanus, E Solje, ... Frontiers in neuroscience 13, 457185, 2019 | 41 | 2019 |
| GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance K Katisko, A Cajanus, N Huber, O Jääskeläinen, T Kokkola, V Kärkkäinen, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (12), 1305-1312, 2021 | 37 | 2021 |
| Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers K Katisko, E Solje, AM Koivisto, J Krüger, T Kinnunen, P Hartikainen, ... Journal of Neuroimmunology 321, 29-35, 2018 | 25 | 2018 |
| Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis A Cajanus, K Katisko, A Kontkanen, O Jääskeläinen, P Hartikainen, ... Annals of clinical and translational neurology 7 (6), 903-910, 2020 | 20 | 2020 |
| Prodromal and early bvFTD: evaluating clinical features and current biomarkers K Katisko, A Cajanus, T Korhonen, AM Remes, A Haapasalo, E Solje Frontiers in Neuroscience 13, 456531, 2019 | 15 | 2019 |
| Comparison of prodromal symptoms of patients with behavioral variant frontotemporal dementia and Alzheimer disease T Korhonen, K Katisko, A Cajanus, P Hartikainen, AM Koivisto, ... Dementia and Geriatric Cognitive Disorders 49 (1), 98-106, 2020 | 14 | 2020 |
| Low prevalence of cancer in patients with frontotemporal lobar degeneration K Katisko, A Haapasalo, A Koivisto, J Krüger, P Hartikainen, V Korhonen, ... Journal of Alzheimer's Disease 62 (2), 789-794, 2018 | 12 | 2018 |
| Peripheral inflammatory markers and clinical correlations in patients with frontotemporal lobar degeneration with and without the C9orf72 repeat expansion K Katisko, E Solje, P Korhonen, O Jääskeläinen, S Loppi, P Hartikainen, ... Journal of Neurology 267, 76-86, 2020 | 10 | 2020 |
| Otsa-ohimolohkorappeumat-miten tunnistan ja hoidan? J Krüger, K Katisko, NM Suhonen, A Haapasalo, AM Remes, E Solje Suomalainen lääkäriseura Duodecim, 2021 | 9 | 2021 |
| The association between frontotemporal lobar degeneration and bullous pemphigoid K Katisko, N Kokkonen, J Krüger, P Hartikainen, AM Koivisto, S Helisalmi, ... Journal of Alzheimer's Disease 66 (2), 743-750, 2018 | 8 | 2018 |
| Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype K Katisko, N Huber, T Kokkola, P Hartikainen, J Krüger, AL Heikkinen, ... Alzheimer's Research & Therapy 14 (1), 151, 2022 | 6 | 2022 |
| Modifiable potential risk factors in familial and sporadic frontotemporal dementia H Soppela, K Katisko, Y Gadola, J Krüger, P Hartikainen, A Alberici, ... Annals of Clinical and Translational Neurology 9 (8), 1195-1205, 2022 | 6 | 2022 |
| Cognitive impairment is not uncommon in patients with biallelic RFC1 AAGGG repeat expansion, but the expansion is rare in patients with cognitive disease A Korpioja, J Krüger, A Hurme-Niiranen, E Solje, K Katisko, J Lipponen, ... Parkinsonism & Related Disorders 103, 98-101, 2022 | 4 | 2022 |
| Brainstem atrophy is linked to extrapyramidal symptoms in frontotemporal dementia S Heikkinen, A Cajanus, K Katisko, P Hartikainen, R Vanninen, ... Journal of Neurology 269 (8), 4488-4497, 2022 | 4 | 2022 |
| Traumatic brain injury associates with an earlier onset in sporadic frontotemporal dementia H Soppela, J Krüger, P Hartikainen, A Koivisto, A Haapasalo, B Borroni, ... Journal of Alzheimer's disease 91 (1), 225-232, 2023 | 3 | 2023 |
| Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer’s Disease K Katisko, J Krüger, H Soppela, P Hartikainen, A Haapasalo, AM Remes, ... Journal of Alzheimer's Disease, 1-9, 2023 | 2 | 2023 |
| C9orf72 repeat expansion does not affect the phenotype in primary progressive aphasia M Haapanen, K Katisko, T Hänninen, J Krüger, P Hartikainen, ... Journal of Alzheimer's Disease 78 (3), 919-925, 2020 | 1 | 2020 |
| Anti-GluA3 autoantibodies define a new sub-population of frontotemporal lobar degeneration patients with distinct neuropathological features M Italia, M Salvadè, F La Greca, E Zianni, S Pelucchi, A Spinola, E Ferrari, ... Brain, Behavior, and Immunity 118, 380-397, 2024 | | 2024 |
| Neurofilament light and glial fibrillary acidic protein in mood and anxiety disorders: A systematic review and meta-analysis MJY Kang, J Grewal, D Eratne, C Malpas, WH Chiu, K Katisko, E Solje, ... medRxiv, 2024.03. 07.24303938, 2024 | | 2024 |
